CLINICAL OUTCOMES OF TEGOPRAZAN OR PPI COMBINATION THERAPY IN PATIENTS TAKING ANTIPLATELET AGENTS AFTER PERCUTANEOUS CORONARY INTERVENTION

被引:0
|
作者
Lee, Jin
Park, Jongha
Park, Jino
Na, Ji Eun
Park, Yong Eun
Choi, Joon Hyuk
Kim, Tae Oh
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1360
引用
收藏
页码:S1313 / S1314
页数:2
相关论文
共 50 条
  • [41] Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia
    Yusuf, Syed Wamique
    Iliescu, Cezar
    Bathina, Jaya D.
    Daher, Iyad N.
    Durand, Jean-Bernard
    TEXAS HEART INSTITUTE JOURNAL, 2010, 37 (03) : 336 - 340
  • [42] Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary Intervention
    Redfors, Bjorn
    Kirtane, Ajay J.
    Liu, Mengdan
    Musikantow, Daniel R.
    Witzenbichler, Bernhard
    Rinaldi, Michael J.
    Metzger, D. Christopher
    Weisz, Giora
    Stuckey, Thomas D.
    Brodie, Bruce R.
    Ben-Yehuda, Ori
    Mehran, Roxana
    Stone, Gregg W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (08) : 797 - 806
  • [43] Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Akin, Ibrahim
    Hamdani, Nazha
    El-Battrawy, Ibrahim
    DRUGS, 2024, : 703 - 705
  • [44] Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Jiang, Jie
    Zheng, Bo
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C135 - C135
  • [45] Outcomes of Percutaneous Coronary Intervention Performed With or Without Preprocedural Dual Antiplatelet Therapy
    Ikegami, Yukinori
    Kohsaka, Shun
    Miyata, Hiroaki
    Ueda, Ikuko
    Fuse, Jun
    Sakamoto, Munehisa
    Shiraishi, Yasuyuki
    Numasawa, Yohei
    Negishi, Koji
    Nakamura, Iwao
    Maekawa, Yuichiro
    Momiyama, Yukihiko
    Fukuda, Keiichi
    CIRCULATION JOURNAL, 2015, 79 (12) : 2598 - +
  • [46] Incidence and Predictors Of Prolonged Dual Antiplatelet Therapy Among Patients After Percutaneous Coronary Intervention
    Zheng, Bo
    Jiang, Jie
    Zhang, Yan
    Yu, Ronghui
    Huo, Yong
    Hong, Tao
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C134 - C135
  • [47] Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Kari L. Olson
    Thomas Delate
    Samuel G. Johnson
    Erika Dawn Wilson
    Daniel M. Witt
    Journal of Thrombosis and Thrombolysis, 2010, 29 : 316 - 321
  • [48] Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention
    Olson, Kari L.
    Delate, Thomas
    Johnson, Samuel G.
    Wilson, Erika Dawn
    Witt, Daniel M.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2010, 29 (03) : 316 - 321
  • [49] One vs 12 Months of Dual Antiplatelet Therapy for Patients After Percutaneous Coronary Intervention
    Tan, Wei Keith
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (17): : 1715 - 1715
  • [50] ACUTE GASTROINTESTINAL BLEEDING AMONG PATIENTS ON ANTIPLATELET AND ANTICOAGULANT THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Sveinsdottir, Asdis
    Gudmundsdottir, Ingibjorg
    Hreinsson, Johann P.
    Andersen, Karl
    Bjornsson, Einar
    GASTROENTEROLOGY, 2018, 154 (06) : S698 - S698